Toby, Garabet G <br/><br/>
Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.  [electronic resource] 

 -  PloS one  2016 
 - e0148255 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0148255  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antithrombin III--pharmacology<br/>Blood Coagulation--drug effects<br/>Blood Coagulation Tests<br/>Coagulants--pharmacology<br/>Disease Models, Animal<br/>Enzyme Activation--physiology<br/>Factor IX--genetics<br/>Factor VIIa--pharmacology<br/>Factor XIa--pharmacology<br/>Half-Life<br/>Hemophilia B--drug therapy<br/>Hemorrhage--drug therapy<br/>Immunoglobulin Fc Fragments--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Recombinant Fusion Proteins--genetics<br/>Thrombin--biosynthesis